This inventor holds 1 USPTO granted patent. Top assignee: Pulmosonix Pty Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Pulmonary Evaluation by Noam Gavriely
Introduction
Noam Gavriely is an accomplished inventor based in Haifa, Israel. He has made significant contributions to the field of medical evaluation, particularly concerning the pulmonary system. His innovative approach combines different evaluative techniques to enhance the diagnosis and treatment of lung conditions.
Latest Patents
Gavriely holds a patent for a method of determining lung condition indicators. This patent describes a microprocessor-controlled device designed for medical evaluation of the pulmonary system. The method incorporates two distinct non-invasive evaluative techniques. Passive auscultation provides indicators of lung condition, while active auscultation offers information that is generally not available from passive methods. By combining the insights from both techniques, Gavriely's invention greatly improves the ability to provide effective medical treatment. He has 1 patent to his name.
Career Highlights
Noam Gavriely has dedicated his career to advancing medical technology. His work at Pulmosonix Pty Ltd. has positioned him as a key player in the development of innovative solutions for pulmonary evaluation. His expertise and commitment to improving patient outcomes have earned him recognition in the medical community.
Collaborations
Gavriely collaborates with Richard G Caro, leveraging their combined expertise to further enhance the capabilities of their medical devices. Their partnership exemplifies the importance of teamwork in driving innovation in healthcare.
Conclusion
Noam Gavriely's contributions to the field of pulmonary evaluation through his innovative patent demonstrate his commitment to improving medical diagnostics. His work continues to pave the way for advancements in the treatment of lung conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile